HHS draft policy eases access to BPC-157 and other peptides over FDA staff objections
AP sources say FDA scientists had little say and opposed the plan. Comments are open for two weeks, and critic Peter Lurie calls it a pre-midterm nod to MAHA voters.
Recap by typeshit. Full story at ClickOnDetroit | WDIV Local 4.